190 related articles for article (PubMed ID: 33717542)
1. The expression patterns and prognostic significance of pleckstrin homology-like domain family A (PHLDA) in lung cancer and malignant mesothelioma.
Baldavira CM; Machado-Rugolo J; Prieto TG; Bastos DR; Balancin M; Ab'Saber AM; Yaegashi LB; Souza PC; Farhat C; Takagaki TY; Nagai MA; Capelozzi VL
J Thorac Dis; 2021 Feb; 13(2):689-707. PubMed ID: 33717542
[TBL] [Abstract][Full Text] [Related]
2. PHLDA1, another PHLDA family protein that inhibits Akt.
Chen Y; Takikawa M; Tsutsumi S; Yamaguchi Y; Okabe A; Shimada M; Kawase T; Sada A; Ezawa I; Takano Y; Nagata K; Suzuki Y; Semba K; Aburatani H; Ohki R
Cancer Sci; 2018 Nov; 109(11):3532-3542. PubMed ID: 30207029
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of Pleckstrin homology-like domain, family A family members in breast cancer.
R Mangone F; Av Valoyes M; G do Nascimento R; Pf Conceição M; R Bastos D; C Pavanelli A; C Soares I; S de Mello E; Nonogaki S; Ab de T Osório C; A Nagai M
Biomark Med; 2020 Nov; 14(16):1537-1552. PubMed ID: 33179538
[No Abstract] [Full Text] [Related]
4. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142223
[TBL] [Abstract][Full Text] [Related]
5. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
[TBL] [Abstract][Full Text] [Related]
6. PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.
Wang X; Li G; Koul S; Ohki R; Maurer M; Borczuk A; Halmos B
Oncotarget; 2018 May; 9(38):24914-24926. PubMed ID: 29861842
[TBL] [Abstract][Full Text] [Related]
7. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Wang F; Zhao N; Gao G; Deng HB; Wang ZH; Deng LL; Yang Y; Lu C
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2851-2859. PubMed ID: 32743759
[TBL] [Abstract][Full Text] [Related]
9. PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells.
Xu J; Bi G; Luo Q; Liu Y; Liu T; Li L; Zeng Q; Wang Q; Wang Y; Yu J; Yi P
J Cancer; 2021; 12(18):5486-5493. PubMed ID: 34405011
[No Abstract] [Full Text] [Related]
10. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
[TBL] [Abstract][Full Text] [Related]
11. Low PHLDA3 expression in oesophageal squamous cell carcinomas is associated with poor prognosis.
Muroi H; Nakajima M; Satomura H; Takahashi M; Yamaguchi S; Sasaki K; Yokobori T; Miyazaki T; Kuwano H; Kato H
Anticancer Res; 2015 Feb; 35(2):949-54. PubMed ID: 25667479
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
13. Pleckstrin homology-like domain, family A, member 1 (
Nagai MA
Biomed Rep; 2016 Mar; 4(3):275-281. PubMed ID: 26998263
[TBL] [Abstract][Full Text] [Related]
14. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
15. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
18. Validating
Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
Front Oncol; 2021; 11():720302. PubMed ID: 34527588
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
20. Expression Patterns of Gli-1, Pleckstrin Homology-Like Domain, Family A, Member 1, Transforming Growth Factor-β1/β2, and p63 in Sebaceous and Follicular Tumors.
Jeon SY; Kim DC; Song KH; Kim KH
Ann Dermatol; 2014 Dec; 26(6):713-21. PubMed ID: 25473223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
